These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
433 related items for PubMed ID: 21523892
1. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kırma C, Erkol A, Pala S, Oduncu V, Dündar C, İzgi A, Tigen K, Gibson CM. Catheter Cardiovasc Interv; 2012 Jan 01; 79(1):59-67. PubMed ID: 21523892 [Abstract] [Full Text] [Related]
2. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G. Circulation; 2008 Jul 01; 118(1):49-57. PubMed ID: 18559698 [Abstract] [Full Text] [Related]
3. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study. Zhu TQ, Zhang Q, Qiu JP, Jin HG, Lu L, Shen J, Zhao LP, Zhang RY, Hu J, Yang ZK, Shen WF. Int J Cardiol; 2013 May 25; 165(3):437-43. PubMed ID: 21940058 [Abstract] [Full Text] [Related]
4. Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction. Yan HB, Li SY, Song L, Wang J, Wu Z, Chi YP, Zheng B, Zhao HJ, Li QX, Zhang XJ, Li WZ. Chin Med J (Engl); 2010 Apr 05; 123(7):877-83. PubMed ID: 20497681 [Abstract] [Full Text] [Related]
5. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF. Coron Artery Dis; 2008 Jun 05; 19(4):271-7. PubMed ID: 18480672 [Abstract] [Full Text] [Related]
7. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study. Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Gaudreault V, Proulx G, Barbeau G, Déry JP, Gleeton O, Manh-Nguyen C, Noël B, Roy L, Costerousse O, De Larochellière R, EArly Discharge after Transradial Stenting of CoronarY Arteries in Acute Myocardial Infarction (EASY-MI) Study Investigators. Am J Cardiol; 2010 Jun 01; 105(11):1520-7. PubMed ID: 20494655 [Abstract] [Full Text] [Related]
8. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, van den Heuvel AF, Tan ES, Pundziute G, van der Werf R, Hoseyni Guyomi S, van der Horst IC, Zijlstra F, de Smet BJ. Circulation; 2010 Dec 21; 122(25):2709-17. PubMed ID: 21098442 [Abstract] [Full Text] [Related]
12. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. Fu XH, Hao QQ, Jia XW, Fan WZ, Gu XS, Wu WL, Hao GZ, Li SQ, Jiang YF, Geng W. Chin Med J (Engl); 2008 Mar 20; 121(6):522-7. PubMed ID: 18364139 [Abstract] [Full Text] [Related]
13. Sestamibi single photon emission computed tomography immediately after primary percutaneous coronary intervention identifies patients at risk for large infarcts. Kaltoft A, Bøttcher M, Sand NP, Rehling M, Andersen NT, Zijlstra F, Nielsen TT. Am Heart J; 2006 May 20; 151(5):1108-14. PubMed ID: 16644346 [Abstract] [Full Text] [Related]